No description available.

No description available.

A esquistossomose é a mais importante das doenças helmínticas humanas em termos de morbidez e mortalidade. A proteína Sm14 de Schistosoma mansoni, que pertence à família de proteínas ligadoras de ácidos graxos (fatty acid-binding proteins, FABPs) (Moser et al., 1991), mostrou um bom nível de proteção (65%) contra a esquistossomose em animais experimentais (Tendler et al., 1996). No presente trabalho foram desenvolvidos sistemas de expressão que possibilitará a produção da proteína Sm14 em larga escala em E.coli. Com o intuito de conhecer a estrutura do gene da proteína Sm14, foi clonado um fragmento de DNA genômico de S. mansoni que contém a seqüência codificante da proteína Sm14. Como os outros membros da família gênica das FABP, o gene para a proteína Sm14 contém quatro \"exons\" separados por três \"introns\" de 674, 585 e 42 bp. Esta é a primeira descrição da estrutura gênica de um membro das FABP correspondente a um helminto. A Sm14 é uma proteína que pode ser potencialmente usada como vacina. Estudamos a existência de polimorfismo em duas linhagens de S. mansoni endêmicas do Brasil: LE e BH. Para a análise de polimorfismo, a ORF correspondente à proteína Sm14 foi amplificada por RT-PCR do RNA total de vermes adultos de S. mansoni. Os produtos de amplificação independentes foram clonados no vetor pGEM-T e seqüenciados. As análises de seqüências mostraram duas isoformas principais para a proteína Sm14: Sm14-M20, com seqüência idêntica a proteína Sm14 previamente reportada para a linhagem de Puerto Rico de S. mansoni (Moser et AL., 1991), e Sm14-T20, onde o códon da Met20 (ATG) mudou para o códon de Thr (ACG) (polimorfismo M20T). Dois clones mostraram uma deleção de seqüência de aminoácidos correspondente ao \"exon\" 3 inteiro (clones ΔExon3), gerada por \"splicing\" alternativo. As outras trocas observadas acontecem em posições onde os aminoácidos são menos conservados e estão representados apenas por um único clone que podem ter sido obtidas por mutagênese na PCR. A metionina correspondente à posição 20 na Sm14 é altamente conservada nas FABP dos mais diversos organismos,e não se tem nenhuma outra proteína com treonina nesta posição. Para o estudo da estrutura e função destas isoformas, os cDNAs correspondentes foram subclonados no vetor pAE (desenvolvido no nosso laboratório), assim como o mutante M20A (Sm14-A20) construído para efeitos de comparação. A estabilidade e estrutura das proteínas recombinantes purificadas foram caracterizadas por dicroísmo circular (CD). A comparação da estrutura e termoestabilidade mostrou que as formas Sm14-T20 e Sm14-A20 são menos termoestáveis do que a Sm14-M20 (um ΔTm de aproximadamente 10°C). Porém, todas as formas de Sm14 foram capazes de ligar o DAUDA [ácido 11-(dansylamino) undecanoico] com a mesma afinidade. Para poder diferenciar as propriedades de ligação de ácidos graxos pelas isoformas, experiências de competição do deslocamento do DAUDA por ácidos graxos naturais, foram realizadas. A partir destes dados podemos assumir que a forma Sm14-M20 liga melhor todos os ácidos graxos naturais testados do que a forma Sm14-T20. Porém esta forma mantém a capacidade de ligar ácidos graxos, ao contrario do mutante Sm14-A20. Pode-se deduzir como resultado destas experiências que a proteína Sm14-M20 é mais estável e liga com maior afinidade os ácidos graxos naturais do que a forma Sm14-T20. Pelo visto, a proteína Sm14-T20 tem menos estrutura-β, porém, mantém a capacidade de ligar moléculas hidrofóbicas. Ainda é desconhecido o papel funcional do polimorfismo da proteína Sm14 no metabolismo dos vermes de S. mansoni. Problemas de estabilidade da proteína Sm14 recombinante, durante seu transporte e armazenamento, comprometem sua viabilidade como vacina. Com o intuito de melhorar a estabilidade desta proteína, foi feita uma mutagênese no único resíduo de cisteína presente na Sm14 na posição 62. Este resíduo é responsável pela formação de dímeros, o que é relacionado a estabilização da perda de estrutura-β e precipitação da proteína. Esta cisteína foi trocada por serina (C62S) e por valina (C62V) por mutagênese sítio dirigida, resultando nas proteínas Sm14-M20S62 e Sm14-M20V62. As formas mutantes não apresentaram maior termoestabilidade, mas a renaturação após o aquecimento a 80°C atingiu quase 100%, diferentemente das proteínas com Cys62. As proteínas com o resíduo de cisteina trocado foram as únicas formas que conservaram a estrutura de β-barril após 3 meses de armazenamento a 4°C, como mostram as análises de dicroísmo circular, sendo a forma mais estável a proteína Sm14-M20V62. Após estes estudos, a isoforma Sm14-M20 com a mutação C62V (Sm14-M20V62) mostrou-se como a melhor alternativa ao antígeno Sm14-T20 usado até agora como modelo de vacina experimental para S. mansoni. Esta indicação deve ser confirmada em ensaios de imunização e posterior desafio com cercárias de S. mansoni. / The schistosomiasis is the most important human helmintic disease in terms of morbidity and mortality. The Sm14 protein of Schistosoma mansoni belongs to the family of fatty acid-binding proteins (FABPs) (Moser et aI. , 1991) and showed a good protection level as vaccine antigen against the schistosomiasis in experimental animals (Tendler et al., 1996). In the present work were developed systems for the expression of Sm14 protein that will facilitate its large scale production in E.coli.. In order to know the gene structure of the Sm14 protein, we amplified by PCR a genomic DNA fragment of S. mansoni that contains the coding sequence for the Sm14 protein. As the other members of the FABP family, the Sm14 gene contains four exons separated by three introns of 674,585 and 42 bp, respectively. This is the first detailed description of the genomic structure for a member of FABPs corresponding to a helmint. We also studied the existence of polymorphisms within two Brazilian endemic strains of S.mansoni: LE and BH. For the polymorphism analysis, the ORF corresponding to the Sm14 protein was amplified by RT-PCR from total RNA of S. mansoni adult worms. The independent amplified products were cloned into pGEM-T vector and sequenced. The sequence analyses showed two main isoforms: Sm14-M20, with identical sequence to that previously reported Sm14 protein from the Puerto Rican strain of S. mansoni (Moser et al., 1991), and Sm14-T20, where the codon for Met20 (ATG) was changed for the Thr codon (ACG) (M20T polymorphism). Two clones showed the same amino acid sequence deletion corresponding to the whole third exon (ΔExon3 clones), generated by alternative splicing. The other observed changes occurred in positions where the amino acids were less conserved and were just represented by only one clone that could be obtained by PCR mutagenesis. The methionine corresponding to the position 20 in Sm14 is highly conserved among FABPs and no other related protein has threonin in this position. To study the structure and function of these amino acid in the isoforms, the corresponding cDNAs were subcloned in to the pAE vector (developed in our laboratory), as well as the mutant M20A (Sm14-A20). The stability and structure of the purified recombinant proteins were characterized by circular dicroism (CD). The comparison of their structure and thermo stability showed that the forms Sm14-T20 and Sm14-A20 are less thermostable than Sm14-M20 (ΔTm around 10ºC). However, all of the Sm14 forms were capable to bind the DAUDA [11- (dansylamine) undecanoic acid] with similar affinities. To differentiate the fatty acid binding properties of Sm14 isoforms, displacement experiments of DAUDA with natural fatty acid were performed. From these data we can assume that the Sm14-M20 form binds better than the Sm14-T20 and Sm14-A20 forms of all natural fatty acid assayed. This suggests that the Sm14-20 protein is most stable and binds better the natural fatty acids than the Sm14-T20 form. Although the Sm14-T20 protein has less structure, it maintains the capacity to bind fatty acids. It is still unknown the functional role of this Sm14 protein polymorphism in the metabolism of S. mansoni worms. Stability problems of the recombinant Sm14 protein during its transport and storage, could hamper its use as vaccine. With the aim to improve the stability of this protein, it was made a mutagenese at the unique cysteine residue present in Sm14 at the position 62. This residue is responsible for the dimer formation and is related the loss of the terciary structure and precipitation of the protein. This cysteine was changed by serine (C62S) and for valine (C62V) by site directed mutagenesis, resulting in the proteins Sm14-M20S62 and Sm14-M20V62. The mutant forms did not present a higher thermal stability but the renaturation after heating at 80°C almost reached 100%, in contrast to Sm14 proteins with Cys62. These mutants conserved the β-barrel structure after 3 months of storage at 4°C, in contrast to proteins with Cys62, as shown by circular dicroism analyses. After these studies, the Sm14-M20 isoform with the C62V mutation (Sm14-M20V62) was considered the best alternative to the antigen Sm14-T20 used up to now as the model for an experimental vaccine for S. mansoni. This indication should be confirmed by immunization and posterior challenge with S. mansoni cercaria.

<p>The parasite <i>Echinococcus granulosus</i> causes hydatid disease, a major zoonosis. A fatty-acid-binding protein, EgFABP1, is important for the parasite, as it must acquire almost all its lipids from its environment or the host. The structure of EgFABP1 has been solved and refined to 1.6 Å resolution. The structure reveals that EgFABP1 has the 10-stranded β-barrel fold typical of the family of intracellular lipid-binding proteins. </p><p>Human semicarbazide-sensitive amine oxidase (SSAO; EC 1.4.3.6), also known as vascular adhesion protein-1, is a copper-containing monoamine oxidase that occurs both as a membrane-bound protein and in a soluble form in plasma. SSAO has been implicated in glucose transport in adipocytes, the differentiation of adipose cells and the leukocyte extravasation process. Toxic reaction products have been suggested to cause some of the vascular complications associated with diabetes and SSAO is therefore of pharmaceutical interest.</p><p>The structure of a truncated, soluble form of human SSAO has been determined to 2.5 Å resolution. The structure reveals that a leucine residue located adjacent to the active site could function as a gate controlling its accessibility. An RGD motif is displayed on the surface where it could be involved in integrin binding and possibly play a role in the shedding of SSAO from the membrane. Carbohydrate moieties are observed at five out of six potential N-glycosylation sites. Carbohydrates attached to Asn 232 flank the active site entrance and might influence substrate specificity. The structure also reveals a vicinal disulfide bridge, which we hypothesise could act as a redox switch involved in the protein’s mechanism of action. The structure of a complex of SSAO and the irreversible inhibitor 2-hydrazinopyridine has been solved and refined to 2.9 Å resolution. Both structures together will aid efforts to identify natural substrates, provide valuable information for the design of specific inhibitors and direct further studies. </p>

The parasite Echinococcus granulosus causes hydatid disease, a major zoonosis. A fatty-acid-binding protein, EgFABP1, is important for the parasite, as it must acquire almost all its lipids from its environment or the host. The structure of EgFABP1 has been solved and refined to 1.6 Å resolution. The structure reveals that EgFABP1 has the 10-stranded β-barrel fold typical of the family of intracellular lipid-binding proteins. Human semicarbazide-sensitive amine oxidase (SSAO; EC 1.4.3.6), also known as vascular adhesion protein-1, is a copper-containing monoamine oxidase that occurs both as a membrane-bound protein and in a soluble form in plasma. SSAO has been implicated in glucose transport in adipocytes, the differentiation of adipose cells and the leukocyte extravasation process. Toxic reaction products have been suggested to cause some of the vascular complications associated with diabetes and SSAO is therefore of pharmaceutical interest. The structure of a truncated, soluble form of human SSAO has been determined to 2.5 Å resolution. The structure reveals that a leucine residue located adjacent to the active site could function as a gate controlling its accessibility. An RGD motif is displayed on the surface where it could be involved in integrin binding and possibly play a role in the shedding of SSAO from the membrane. Carbohydrate moieties are observed at five out of six potential N-glycosylation sites. Carbohydrates attached to Asn 232 flank the active site entrance and might influence substrate specificity. The structure also reveals a vicinal disulfide bridge, which we hypothesise could act as a redox switch involved in the protein’s mechanism of action. The structure of a complex of SSAO and the irreversible inhibitor 2-hydrazinopyridine has been solved and refined to 2.9 Å resolution. Both structures together will aid efforts to identify natural substrates, provide valuable information for the design of specific inhibitors and direct further studies.

The pathogenesis of insulin resistance is a complex and still intensively studied issue. Endocrine and paracrine activity of the adipose tissue together with mi- tochondrial dysfunction are the most discussed potential factors included in the development of insulin resistance. In the first part of our study we examined the involvement of the adipose tissue and its secretory products in the etiopathogenesis of insulin resistance in patients with Cushing's syndrome, acromegaly and simple obesity. We focused on three important regulators of metabolic homeostasis - fibroblast growth factors 21 and 19 (FGF-21 and FGF-19) and adipocyte fatty acid binding protein (FABP-4). We found significantly elevated circulating levels of FGF-21 and FABP-4 ac- companying insulin resistance in both patients with simple obesity and patients with obesity connected to Cushing's syndrome, as compared to healthy controls. The concentrations of both substances were comparable between hypercortisolic and obese patients. This finding together with the absence of correlation be- tween the levels of FGF-21 resp. FABP-4 and cortisol suggest that the reason for elevation of their concentrations is obesity and its metabolic consequences themselves rather then the effect of hypercortisolism on FGF-21 and FABP-4 production. We found no...

A esquistossomose é a mais importante das doenças helmínticas humanas em termos de morbidez e mortalidade. A proteína Sm14 de Schistosoma mansoni, que pertence à família de proteínas ligadoras de ácidos graxos (fatty acid-binding proteins, FABPs) (Moser et al., 1991), mostrou um bom nível de proteção (65%) contra a esquistossomose em animais experimentais (Tendler et al., 1996). No presente trabalho foram desenvolvidos sistemas de expressão que possibilitará a produção da proteína Sm14 em larga escala em E.coli. Com o intuito de conhecer a estrutura do gene da proteína Sm14, foi clonado um fragmento de DNA genômico de S. mansoni que contém a seqüência codificante da proteína Sm14. Como os outros membros da família gênica das FABP, o gene para a proteína Sm14 contém quatro \"exons\" separados por três \"introns\" de 674, 585 e 42 bp. Esta é a primeira descrição da estrutura gênica de um membro das FABP correspondente a um helminto. A Sm14 é uma proteína que pode ser potencialmente usada como vacina. Estudamos a existência de polimorfismo em duas linhagens de S. mansoni endêmicas do Brasil: LE e BH. Para a análise de polimorfismo, a ORF correspondente à proteína Sm14 foi amplificada por RT-PCR do RNA total de vermes adultos de S. mansoni. Os produtos de amplificação independentes foram clonados no vetor pGEM-T e seqüenciados. As análises de seqüências mostraram duas isoformas principais para a proteína Sm14: Sm14-M20, com seqüência idêntica a proteína Sm14 previamente reportada para a linhagem de Puerto Rico de S. mansoni (Moser et AL., 1991), e Sm14-T20, onde o códon da Met20 (ATG) mudou para o códon de Thr (ACG) (polimorfismo M20T). Dois clones mostraram uma deleção de seqüência de aminoácidos correspondente ao \"exon\" 3 inteiro (clones &#916;Exon3), gerada por \"splicing\" alternativo. As outras trocas observadas acontecem em posições onde os aminoácidos são menos conservados e estão representados apenas por um único clone que podem ter sido obtidas por mutagênese na PCR. A metionina correspondente à posição 20 na Sm14 é altamente conservada nas FABP dos mais diversos organismos,e não se tem nenhuma outra proteína com treonina nesta posição. Para o estudo da estrutura e função destas isoformas, os cDNAs correspondentes foram subclonados no vetor pAE (desenvolvido no nosso laboratório), assim como o mutante M20A (Sm14-A20) construído para efeitos de comparação. A estabilidade e estrutura das proteínas recombinantes purificadas foram caracterizadas por dicroísmo circular (CD). A comparação da estrutura e termoestabilidade mostrou que as formas Sm14-T20 e Sm14-A20 são menos termoestáveis do que a Sm14-M20 (um &#916;Tm de aproximadamente 10°C). Porém, todas as formas de Sm14 foram capazes de ligar o DAUDA [ácido 11-(dansylamino) undecanoico] com a mesma afinidade. Para poder diferenciar as propriedades de ligação de ácidos graxos pelas isoformas, experiências de competição do deslocamento do DAUDA por ácidos graxos naturais, foram realizadas. A partir destes dados podemos assumir que a forma Sm14-M20 liga melhor todos os ácidos graxos naturais testados do que a forma Sm14-T20. Porém esta forma mantém a capacidade de ligar ácidos graxos, ao contrario do mutante Sm14-A20. Pode-se deduzir como resultado destas experiências que a proteína Sm14-M20 é mais estável e liga com maior afinidade os ácidos graxos naturais do que a forma Sm14-T20. Pelo visto, a proteína Sm14-T20 tem menos estrutura-&#946;, porém, mantém a capacidade de ligar moléculas hidrofóbicas. Ainda é desconhecido o papel funcional do polimorfismo da proteína Sm14 no metabolismo dos vermes de S. mansoni. Problemas de estabilidade da proteína Sm14 recombinante, durante seu transporte e armazenamento, comprometem sua viabilidade como vacina. Com o intuito de melhorar a estabilidade desta proteína, foi feita uma mutagênese no único resíduo de cisteína presente na Sm14 na posição 62. Este resíduo é responsável pela formação de dímeros, o que é relacionado a estabilização da perda de estrutura-&#946; e precipitação da proteína. Esta cisteína foi trocada por serina (C62S) e por valina (C62V) por mutagênese sítio dirigida, resultando nas proteínas Sm14-M20S62 e Sm14-M20V62. As formas mutantes não apresentaram maior termoestabilidade, mas a renaturação após o aquecimento a 80°C atingiu quase 100%, diferentemente das proteínas com Cys62. As proteínas com o resíduo de cisteina trocado foram as únicas formas que conservaram a estrutura de &#946;-barril após 3 meses de armazenamento a 4°C, como mostram as análises de dicroísmo circular, sendo a forma mais estável a proteína Sm14-M20V62. Após estes estudos, a isoforma Sm14-M20 com a mutação C62V (Sm14-M20V62) mostrou-se como a melhor alternativa ao antígeno Sm14-T20 usado até agora como modelo de vacina experimental para S. mansoni. Esta indicação deve ser confirmada em ensaios de imunização e posterior desafio com cercárias de S. mansoni. / The schistosomiasis is the most important human helmintic disease in terms of morbidity and mortality. The Sm14 protein of Schistosoma mansoni belongs to the family of fatty acid-binding proteins (FABPs) (Moser et aI. , 1991) and showed a good protection level as vaccine antigen against the schistosomiasis in experimental animals (Tendler et al., 1996). In the present work were developed systems for the expression of Sm14 protein that will facilitate its large scale production in E.coli.. In order to know the gene structure of the Sm14 protein, we amplified by PCR a genomic DNA fragment of S. mansoni that contains the coding sequence for the Sm14 protein. As the other members of the FABP family, the Sm14 gene contains four exons separated by three introns of 674,585 and 42 bp, respectively. This is the first detailed description of the genomic structure for a member of FABPs corresponding to a helmint. We also studied the existence of polymorphisms within two Brazilian endemic strains of S.mansoni: LE and BH. For the polymorphism analysis, the ORF corresponding to the Sm14 protein was amplified by RT-PCR from total RNA of S. mansoni adult worms. The independent amplified products were cloned into pGEM-T vector and sequenced. The sequence analyses showed two main isoforms: Sm14-M20, with identical sequence to that previously reported Sm14 protein from the Puerto Rican strain of S. mansoni (Moser et al., 1991), and Sm14-T20, where the codon for Met20 (ATG) was changed for the Thr codon (ACG) (M20T polymorphism). Two clones showed the same amino acid sequence deletion corresponding to the whole third exon (&#916;Exon3 clones), generated by alternative splicing. The other observed changes occurred in positions where the amino acids were less conserved and were just represented by only one clone that could be obtained by PCR mutagenesis. The methionine corresponding to the position 20 in Sm14 is highly conserved among FABPs and no other related protein has threonin in this position. To study the structure and function of these amino acid in the isoforms, the corresponding cDNAs were subcloned in to the pAE vector (developed in our laboratory), as well as the mutant M20A (Sm14-A20). The stability and structure of the purified recombinant proteins were characterized by circular dicroism (CD). The comparison of their structure and thermo stability showed that the forms Sm14-T20 and Sm14-A20 are less thermostable than Sm14-M20 (&#916;Tm around 10ºC). However, all of the Sm14 forms were capable to bind the DAUDA [11- (dansylamine) undecanoic acid] with similar affinities. To differentiate the fatty acid binding properties of Sm14 isoforms, displacement experiments of DAUDA with natural fatty acid were performed. From these data we can assume that the Sm14-M20 form binds better than the Sm14-T20 and Sm14-A20 forms of all natural fatty acid assayed. This suggests that the Sm14-20 protein is most stable and binds better the natural fatty acids than the Sm14-T20 form. Although the Sm14-T20 protein has less structure, it maintains the capacity to bind fatty acids. It is still unknown the functional role of this Sm14 protein polymorphism in the metabolism of S. mansoni worms. Stability problems of the recombinant Sm14 protein during its transport and storage, could hamper its use as vaccine. With the aim to improve the stability of this protein, it was made a mutagenese at the unique cysteine residue present in Sm14 at the position 62. This residue is responsible for the dimer formation and is related the loss of the terciary structure and precipitation of the protein. This cysteine was changed by serine (C62S) and for valine (C62V) by site directed mutagenesis, resulting in the proteins Sm14-M20S62 and Sm14-M20V62. The mutant forms did not present a higher thermal stability but the renaturation after heating at 80°C almost reached 100%, in contrast to Sm14 proteins with Cys62. These mutants conserved the &#946;-barrel structure after 3 months of storage at 4°C, in contrast to proteins with Cys62, as shown by circular dicroism analyses. After these studies, the Sm14-M20 isoform with the C62V mutation (Sm14-M20V62) was considered the best alternative to the antigen Sm14-T20 used up to now as the model for an experimental vaccine for S. mansoni. This indication should be confirmed by immunization and posterior challenge with S. mansoni cercaria.

The pathogenesis of insulin resistance is a complex and still intensively studied issue. Endocrine and paracrine activity of the adipose tissue together with mi- tochondrial dysfunction are the most discussed potential factors included in the development of insulin resistance. In the first part of our study we examined the involvement of the adipose tissue and its secretory products in the etiopathogenesis of insulin resistance in patients with Cushing's syndrome, acromegaly and simple obesity. We focused on three important regulators of metabolic homeostasis - fibroblast growth factors 21 and 19 (FGF-21 and FGF-19) and adipocyte fatty acid binding protein (FABP-4). We found significantly elevated circulating levels of FGF-21 and FABP-4 ac- companying insulin resistance in both patients with simple obesity and patients with obesity connected to Cushing's syndrome, as compared to healthy controls. The concentrations of both substances were comparable between hypercortisolic and obese patients. This finding together with the absence of correlation be- tween the levels of FGF-21 resp. FABP-4 and cortisol suggest that the reason for elevation of their concentrations is obesity and its metabolic consequences themselves rather then the effect of hypercortisolism on FGF-21 and FABP-4 production. We found no...

No description available.

Conditions which promote reversible growth arrest, such as hypoxia and high cell density, lead to activation of a diverse network of proteins known as growth arrest specific (GAS) genes. Fatty acid binding protein 4 (FABP4), a lipid chaperone involved in the regulation of metabolic and inflammatory responses, has been shown to be part of the GAS program. While the induction of FABP4 in oxygen-deprived environments is well characterized, its functionality and regulation in such conditions remains unclear. In this study, we describe how mis-expression of FABP4 affects cell viability and survival within low oxygen conditions. Loss of FABP4 using shRNA was shown to be associated with a significant increase in oxidative stress and lipid peroxidation, a reduction in lipid droplet formation and a greater incidence of apoptosis. Hypoxia-mediated expression of FABP4 was also found to be positively correlated with cellular levels of C/EBP-beta, an essential activator of p20K in quiescence. FABP4 and p20K are both lipocalins that have been shown to share similar induction patterns and ability to assist in the maintenance of lipid trafficking in cellular stress circumstances. Unexpectedly, the depletion of FABP4 or p20K results in loss of the other in limited oxygen concentrations. This occurs independently of disruption to the broad GAS gene program, suggesting the two proteins may be co-regulated in a shared hypoxic-signalling pathway. C/EBP-beta appears to be the transcriptional activator shared by FABP4 and p20K in quiescence, and the three may be part of an intricate system to sense and respond to reactive oxygen species and lipid radicals. However, the forced expression of either FABP4 or p20K when the other is repressed only moderately restores cell survival through alleviating oxidative stress, indicating the two are both necessary for optimal response to hypoxia. In all, these studies suggest that analogous to the p20K lipocalin, FABP4 plays a critical role in lipid homeostasis and cell survival in conditions of limited oxygen concentrations, and its stimulation is dependent on C/EBP-beta activity. / Thesis / Master of Science (MSc) / A study investigating the role of FABP4 and p20K in conditions of reversible growth arrest with an emphasis on cell survival, lipid homeostasis and mitigating the effects of oxidative stress, and regulation of the two lipocalins by C/EBP-beta.